Australia, Jan. 22 -- Bayer AG, owns the trademark (2569851) for 'ARNUVEQS' till June 16, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment of soil-transmitted helminthiasis and onchocerciasis; pharmaceutical preparations, namely anthelmintic agents.]
Type of Mark: Word
Date of Acceptance: Nov. 14, 2025
Registration Advertised: Jan. 21
For further details contact Griffith Hack and Nicole Haberecht.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2569851.
Disclaimer: Curated by HT Syndication.
